LEADER 01105nam0-2200361---450-
001 990001075370203316
005 20020506164408.0
010   $a0-89603-670-7
035   $a000107537
035   $aUSA01000107537
035   $a(ALEPH)000107537USA01
035   $a000107537
100   $a20020506d2001----km|y0itay0103----ba
101 0 $aeng
102   $aUS
105   $aa|||||||001yy
200 1 $aAntimalarial chemotherapy$emechanism of action, resistance, and new directions in drug discovery$fPhilip J. Rosenthal
210   $aTotowa (N.J.)$cHumana Press$dc2001
215   $aXI, 396 p.$cill.$d26 cm
225 2 $aInfections disease
410  1$12001$aInfections disease
606 0 $aMalaria$xTerapia
676   $a616.9362061
700  1$aROSENTHAL,$bPhilip J.$0553695
801  0$aIT$bsalbc$gISBD
912   $a990001075370203316
951   $a616.936 206 1 ROS$b2989 Farm.$c616$d00081247
959   $aBK
969   $aFAR
979   $aJOHNNY$b90$c20020506$lUSA01$h1644
979   $aPATRY$b90$c20040406$lUSA01$h1714
996   $aAntimalarial chemotherapy$9979206
997   $aUNISA